Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer (Tax-Over)

This study has been completed.
Information provided by:
Sanofi Identifier:
First received: October 13, 2008
Last updated: October 28, 2009
Last verified: October 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)